Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 40

1.

BST-236, a novel cytarabine prodrug for patients with acute leukemia unfit for standard induction: a phase 1/2a study.

Zuckerman T, Ram R, Akria L, Koren-Michowitz M, Hoffman R, Henig I, Lavi N, Ofran Y, Horowitz NA, Nudelman O, Tavor S, Yeganeh S, Gengrinovitch S, Flaishon L, Tessler S, Ben Yakar R, Rowe JM.

Blood Adv. 2019 Nov 26;3(22):3740-3749. doi: 10.1182/bloodadvances.2019000468.

2.

Design, production and purification of a novel recombinant gonadotropin-releasing hormone associated peptide as a spawning inducing agent for fish.

Mohammadzadeh S, Moradian F, Yeganeh S, Falahatkar B, Milla S.

Protein Expr Purif. 2020 Feb;166:105510. doi: 10.1016/j.pep.2019.105510. Epub 2019 Oct 16.

PMID:
31628987
3.

Expression of miR-Let-7a, miR-15a, miR-16-1, and their target genes in fresh and vitrified embryos and its surrounding culture media for noninvasive embryo assessment.

Heidari F, Hosseini S, Yeganeh SM, Salehi M.

J Cell Biochem. 2019 Dec;120(12):19691-19698. doi: 10.1002/jcb.29275. Epub 2019 Jul 11.

PMID:
31297859
4.

The effect of Spirulina platensis meal on antioxidant gene expression, total antioxidant capacity, and lipid peroxidation of rainbow trout (Oncorhynchus mykiss).

Teimouri M, Yeganeh S, Mianji GR, Najafi M, Mahjoub S.

Fish Physiol Biochem. 2019 Jun;45(3):977-986. doi: 10.1007/s10695-019-0608-3. Epub 2019 Jan 16.

PMID:
30648194
5.

Assessment of the knowledge and attitude of infants' mothers from Bushehr (Iran) on food security using anthropometric indicators in 2016: a cross-sectional study.

Yeganeh S, Motamed N, NajafpourBoushehri S, Ravanipour M.

BMC Public Health. 2018 May 11;18(1):621. doi: 10.1186/s12889-018-5531-5.

6.

Effect of sodium selenite on the bacteria growth, selenium accumulation, and selenium biotransformation in Pediococcus acidilactici.

Kousha M, Yeganeh S, Keramat Amirkolaie A.

Food Sci Biotechnol. 2017 Jul 20;26(4):1013-1018. doi: 10.1007/s10068-017-0142-y. eCollection 2017.

7.

Combined Evaluation of AFP, CA15-3, CA125, CA19-9, and CEA Tumor Markers in Patients with Hepatitis B and C.

Assmar M, Yeganeh S, Mansourghanaei F, Amirmozafari N.

Iran J Public Health. 2016 Dec;45(12):1645-1651.

8.

Effect of Potential Probiotic Lactococcus lactis Subsp. lactis on Growth Performance, Intestinal Microbiota, Digestive Enzyme Activities, and Disease Resistance of Litopenaeus vannamei.

Adel M, El-Sayed AM, Yeganeh S, Dadar M, Giri SS.

Probiotics Antimicrob Proteins. 2017 Jun;9(2):150-156. doi: 10.1007/s12602-016-9235-9.

PMID:
27822707
9.

Effects of dietary Spirulina platensis on growth performance, humoral and mucosal immune responses and disease resistance in juvenile great sturgeon (Huso huso Linnaeus, 1754).

Adel M, Yeganeh S, Dadar M, Sakai M, Dawood MAO.

Fish Shellfish Immunol. 2016 Sep;56:436-444. doi: 10.1016/j.fsi.2016.08.003. Epub 2016 Aug 6.

PMID:
27506276
10.

Assessment of heavy metal enrichment in the offshore fine-grained sediments of the Caspian Sea.

Pakzad HR, Pasandi M, Yeganeh S, Lahijani HA.

Environ Monit Assess. 2016 May;188(5):303. doi: 10.1007/s10661-016-5302-7. Epub 2016 Apr 21.

PMID:
27102772
11.

An alerting sign: Enlarged cardiac silhouette.

Hamiel U, Yeganeh S, Carrasso S, Soboh S.

Cleve Clin J Med. 2015 Dec;82(12):801-3. doi: 10.3949/ccjm.82a.14185. No abstract available.

12.

Dietary effects of Spirulina platensis on hematological and serum biochemical parameters of rainbow trout (Oncorhynchus mykiss).

Yeganeh S, Teimouri M, Amirkolaie AK.

Res Vet Sci. 2015 Aug;101:84-8. doi: 10.1016/j.rvsc.2015.06.002. Epub 2015 Jun 20.

PMID:
26267095
13.

Aflatoxin M1 Concentration in Various Dairy Products: Evidence for Biologically Reduced Amount of AFM1 in Yoghurt.

Rahimirad A, Maalekinejad H, Ostadi A, Yeganeh S, Fahimi S.

Iran J Public Health. 2014 Aug;43(8):1139-44.

14.

Outcomes of light-chain amyloidosis patients treated with first-line bortezomib: a collaborative retrospective multicenter assessment.

Gatt ME, Hardan I, Chubar E, Suriu C, Tadmor T, Shevetz O, Patachenco P, Dally N, Yeganeh S, Ballan-Haj M, Cohen Y, Trestman S, Muchtar E, Magen H, Jakubinsky J, Avivi I; Israeli MM study group.

Eur J Haematol. 2016 Feb;96(2):136-43. doi: 10.1111/ejh.12558. Epub 2015 Apr 17.

PMID:
25827161
15.

Higher infection rate after 7- compared with 5-day cycle of azacitidine in patients with higher-risk myelodysplastic syndrome.

Ofran Y, Filanovsky K, Gafter-Gvili A, Vidal L, Aviv A, Gatt ME, Silbershatz I, Herishanu Y, Arad A, Tadmor T, Dally N, Nemets A, Rouvio O, Ronson A, Herzog-Tzarfati K, Akria L, Braester A, Hellmann I, Yeganeh S, Nagler A, Leiba R, Mittelman M, Merkel D.

Clin Lymphoma Myeloma Leuk. 2015 Jun;15(6):e95-9. doi: 10.1016/j.clml.2015.02.030. Epub 2015 Mar 5.

PMID:
25819366
16.

Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis.

Schulman S, Kakkar AK, Goldhaber SZ, Schellong S, Eriksson H, Mismetti P, Christiansen AV, Friedman J, Le Maulf F, Peter N, Kearon C; RE-COVER II Trial Investigators.

Circulation. 2014 Feb 18;129(7):764-72. doi: 10.1161/CIRCULATIONAHA.113.004450. Epub 2013 Dec 16.

PMID:
24344086
17.

Ensemble Semi-supervised Frame-work for Brain Magnetic Resonance Imaging Tissue Segmentation.

Azmi R, Pishgoo B, Norozi N, Yeganeh S.

J Med Signals Sens. 2013 Apr;3(2):94-106.

18.

Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism.

Hokusai-VTE Investigators, Büller HR, Décousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, Raskob GE, Schellong SM, Schwocho L, Segers A, Shi M, Verhamme P, Wells P.

N Engl J Med. 2013 Oct 10;369(15):1406-15. doi: 10.1056/NEJMoa1306638. Epub 2013 Aug 31. Erratum in: N Engl J Med. 2014 Jan 23;370(4):390.

19.

Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: a retrospective multicenter study.

Merkel D, Filanovsky K, Gafter-Gvili A, Vidal L, Aviv A, Gatt ME, Silbershatz I, Herishanu Y, Arad A, Tadmor T, Dally N, Nemets A, Rouvio O, Ronson A, Herzog-Tzarfati K, Akria L, Braester A, Hellmann I, Yeganeh S, Nagler A, Leiba R, Mittelman M, Ofran Y.

Am J Hematol. 2013 Feb;88(2):130-4. doi: 10.1002/ajh.23368.

20.

Use of oral direct factor Xa inhibiting anticoagulants in elective hip and knee arthroplasty: a meta-analysis of efficacy and safety profiles compared with those of low-molecular-weight heparins.

As-Sultany M, Pagkalos J, Yeganeh S, Craigs CL, Korres N, West RM, Tsiridis E.

Curr Vasc Pharmacol. 2013 May;11(3):366-75. Review.

PMID:
23140527

Supplemental Content

Loading ...
Support Center